A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press release.

Patients with specific dermatological immune-mediated inflammatory diseases are not at increased risk of developing severe COVID-19.

At this week’s American Chemical Society Spring meeting, Galderma SA reported the discovery of novel, oral and selective macrocyclic inhibitors of protein kinase C θ (PKCθ) for the potential treatment ...

The family-run business has created a range of products using snail mucin to treat problematic skin naturally and effectively ...

Scalp pain or tenderness can have a variety of causes including trauma, psoriasis, dermatitis, folliculitis, infections, or even your hairstyle. Underlying conditions like headaches or migraines could ...

Almirall has announced that it will be hosting the 16th edition of its Skin Academy, a conference that encourages ...

Patients with atopic dermatitis, psoriasis, or vitiligo who use immunosuppressants or were vaccinated against COVID-19 are not at an increased risk of developing COVID-19. Progressive disease ...